Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Mary Hobart, PhD
JCP
Original Research
Effects of Brexpiprazole on Functioning in Schizophrenia
March 1, 2022
Drawing on 4 RCTs and 2 open-label extension studies of brexpiprazole, this analysis looks at the effects of this medication on functioning both in the short term and over...
Christoph U. Correll
,
Ying He
,
François Therrien
, et al
JCP
Original Research
Efficacy and Safety of Adjunctive Brexpiprazole in MDD
May 22, 2018
Finding effective treatment for depressed patients who do not adequately respond to antidepressant medications is a frequent challenge for clinicians. Read this article to learn about the efficacy, safety,...
Mary Hobart
,
Aleksandar Skuban
,
Peter Zhang
, et al
JCP
Original Research
Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study
September 23, 2015
Michael E. Thase
,
James M. Youakim
,
Aleksandar Skuban
, et al
JCP
Original Research
Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder: A Phase 3, Randomized, Placebo-Controlled Study in Patients With Inadequate Response to Antidepressants
September 23, 2015
Michael E. Thase
,
James M. Youakim
,
Aleksandar Skuban
, et al
